FPCT Table of Contents

From FETAL PRECURSOR CELL TRANSPLANTATION (FPCT)
Revision as of 16:57, 12 March 2017 by Sysop (talk | contribs) (I.DEFINITIONS and BASICS)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

FETAL PRECURSOR CELL TRANSPLANTATION (FPCT)

PREFACE

I.DEFINITIONS and BASICS

  1. Fetal precursor cell xeno-transplantation vs. fetal precursor cell allo-transplantation
  2. Fraud in stem cell transplantation
    1. Quick practical advice
    2. SCIENTIFIC FACTS
  3. History
  4. Legislative situation
    1. European Community
    2. U.S.A.
      1. PHS Guideline on Infectious Disease Issues in Xenotransplantation
    3. Other countries
  5. Safety issues

II.SCIENTIFIC BASIS OF CLINICAL USE OF FETAL PRECURSOR CELL TRANSPLANTATION

  1. Essential facts
  2. Cytology
  3. Cell anatomy
  4. Cell death
  5. Cell biology
  6. Physiology
  7. Biochemistry
  8. Medical genetics
  9. Comparative Embryology
  10. Growth & Development
  11. Aging process
  12. Immunology
  13. Transmission of infection
  14. Cancerogenesis
  15. Pre-clinical vs. clinical studies
  16. Artificial organs and bio-prostheses for reconstructive surgery
  17. ADDENDUM

III.MANUFACTURE OF FETAL PRECURSOR CELL TRANSPLANTS

  1. Preparation and manufacture of fetal precursor cell transplants
  2. Animal sources for fetal precursor cell transplants
  3. Closed colony of source animals
  4. Screening for infectious agents / Individual qualification of animal sources
  5. Procurement of fetal precursor cell transplants
  6. Archiving of medical records and specimens from animal sources
  7. Quality control
  8. Release and labeling of fetal precursor cell transplants

IV.CLINICAL TREATMENT BY FETAL PRECURSOR CELL TRANSPLANTATION IN HUMAN MEDICINE

  1. Therapeutic goal of fetal precursor cell transplantation
  2. General principles of therapeutic application
  3. Concurrent treatment by fetal precursor cell transplantation and pharmaceutical drugs of chemical nature
  4. Concurrent treatment by fetal precursor cell transplantation and medications prepared by biotechnological methods
  5. Treatment of iatrogenic diseases by fetal precursor cell transplantation
  6. Mono- vs. poly-therapy by fetal precursor cell transplantation
  7. Description of various fetal precursor cell transplants
  8. Indications / Contraindications
  9. Patient’s preparation for fetal precursor transplantation
  10. Treatment procedure
  11. Post fetal precursor cell transplantation precautions and patient monitoring
  12. Patient’s pre- and post-treatment instructions
  13. Surveillance for possible transmission of xeno-zoonoses
  14. Surveillance for possible immunological reactions after BCRO fetal precursor cell transplantation
  15. Mechanism of action
  16. Complications

V.CLINICAL TREATMENT BY BCRO FETAL PRECURSOR CELL TRANSPLANTATION

  1. Genetic Diseases
  2. Chromosomal Disease
  3. Neonatal, Perinatal Diseases
  4. Autism
  5. Aging Disease
  6. Endocrine Diseases
    1. Diabetes Mellitus
    2. Adrenal Cortex
    3. Gonads
    4. Parathyroid Glands
    5. Thyroid
  7. Immune System Diseases
  8. Autoimmune Diseases
  9. Cancer Treatment
  10. Hematological Diseases
  11. Treatment of Radiation Injuries
  12. Diseases of Central Nervous System
  13. Diseases of Locomotor Apparatus
  14. Digestive System Diseases
  15. Liver Diseases
  16. Metabolic Diseases
  17. Kidney Diseases
  18. Cardiovascular Diseases
  19. Lung Diseases
  20. Skin Diseases

VI.BIBLIOGRAPHY

VII.ABBREVIATIONS

CURRICULUM VITAE